A highly bullish technical trade alert has been issued on Generex Biotechnology Corporation (NASDAQ:GNBT) on the even of the N.I.C.E. conference news. The company was recently introduced on our website as one of the most undervalued biotechnology companies of the early 2010 year, keeping investors glued to the screen as they await any new developments. [...]
Generex Biotechnology Corporation (Public, NASDAQ:GNBT) Anna Gluskin, CEO of Generex Biotechnology (NASDAQ:GNBT), talks about the company’s oral treatment for diabetes along with a cancer vaccine under development. MarketWatch’s Kristen Gerencher reports from the J.P. Morgan health-care conference in San Francisco. Highlights Oral-Lyn is a liquid spray which allows the patients to be treated without injections [...]
Generex Biotechnology Corporation (Public, NASDAQ: GNBT) This past year, small cap biotech investors were witness to some of the most profitable gains ever recorded. The only way to encapsulate it would be through two simple words, “FDA Approval”. Yes, any company with high probability of approval on their blockbuster drugs saw their shares literally explode [...]
